Quotables
"Fooling around with alternating current is just a waste of time. Nobody will use it, ever."
Thomas Edison ; 1889
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7323461 | Use of methylene blue and related compounds to prevent or reverse an exaggerated hemodynamic reaction The present invention relates to the use of the dye methylene blue (MB) or a related compound to prevent or reverse an exaggerated hemodynamic reaction in animals in need thereof, including humans. More specifically, the present invention concerns the use of MB or a... | 01/29/2008 |
| 7309502 | Pharmaceutical compositions for treating and saving and the method for the preparation thereof The present invention relates to a pharmaceutical composition and the method for the preparation thereof. The composition comprises 1.5˜6.9% (w/v) of one or more substances selected from sodium chloride, sodium bicarbonate, potassium chloride, magnesium sulfate, ca... | 12/18/2007 |
| 7097858 | Polyoxometalate materials, metal-containing materials, and methods of use thereof Polyoxometalate topical compositions for removing contaminants from an environment and methods of use thereof are disclosed. An embodiment of the polyoxometalate topical composition includes a topical carrier and at least one polyoxometalate, with the proviso that t... | 08/29/2006 |
| 6986905 | Pharmaceutical compositions for treating and saving and the method for the preparation thereof The present invention relates to a pharmaceutical composition and the method for the preparation thereof, The composition comprises 1.5˜6.9% (w/v) of one or more substances selected from sodium chloride, sodium bicarbonate, potassium chloride, magnesium sulfate, ca... | 01/17/2006 |
| 6723349 | Polyoxometalate materials, metal-containing materials, and methods of use thereof The invention relates to a polyoxometalate topical composition for removing a contaminant from an environment, comprising a topical carrier and at least one polyoxometalate, with the proviso that the polyoxometalate is not H5PV2Mo10O... | 04/20/2004 |
| 6518319 | Method of preparing and using compositions extracted from vegetable matter for the treatment of female symptoms A composition is prepared by extracting phytochemicals from plant matter. This composition is enriched preferably in isoflavones, lignans, saponins, catechins and phenolic acids. Soy is the preferred source of these chemicals; however, other plants may al... | 02/11/2003 |
| 6114347 | Pharmaceutical formulation for the prophylaxis and pretreatment of a poisoning caused by organophosphorus cholinesterase inhibitors A pharmaceutical formulation for the prophylaxis and preliminary treatment of a poisoning caused by organophosphorus cholinesterase inhibitors is characterized in that it consists of an active substance combination of at least one parasympathomimetic and ... | 09/05/2000 |
| 5981555 | Compositions, kits and methods for administration of antilipemic drugs The present invention concerns composition, kits and methods for reducing the flushing effect (cutaneous erythema) of an antilipemic drug, for treating hyperlipemia, for improving the effectiveness of an anti-platelet aggregating drug (e.g., in nonrespond... | 11/09/1999 |
| 5854291 | Pain reliever and method of use A composition containing capsaicin together with another ingredient to neutralize the discomfort resulting from the application of capsaicin to the skin can be used to treat many types of discomforts, including arthritis pain, hemorrhoid pain and itching,... | 12/29/1998 |
| 5852055 | Pharmaceutical compositions comprising paracetamol and L-cysteine or a precursor thereof An improved process for the production of a pharmaceutical composition comprising p-hydroxyacetanilide and L-cysteine or a compound which is converted thereto in vivo comprises mixing p-hydroxyacetanilide and L-cysteine or its precursor in the solid state... | 12/22/1998 |
| 5834477 | Opiate analgesic formulation with improved safety An opiate analgesic drug formulation which induces minimal respiratory dession is provided which contains a homogeneous mixture of an opiate agonist drug component and an opiate antagonist drug component in an aqueous medium, the opiate agonist component... | 11/10/1998 |
| 5814635 | Concentrated injection solution of alkali metal salts of reduced folates A concentrated, stable solution, especially an injection solution, which comprises water and either sodium-leucovorin or potassium-leucovorin or sodium-N(5)-methyl-5,6,7,8-tetrahydrofolic acid or potassium-N(5)-methyl-5,6,7,8-tetrahydrofolic acid. Also de... | 09/29/1998 |
| 5811451 | Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies The combined use of opiate antagonists and of calcium salts for the preparation of medicaments for the treatment of endorphin-mediated pathologies is described.... | 09/22/1998 |
| 5795586 | Toxin decontaminant food product and method of forming same An antidotal food product containing activated charcoal is provided for ingestion into the gastro-intestinal tract of a user. The antidotal food product is orally administered having the visual appearance and physical properties which enables the desire o... | 08/18/1998 |
| 5773453 | Methods for administration of antilipemic drugs The present invention concerns methods for reducing cutaneous flushing in a patient to whom niacin is administered. According to the present method, two or more doses of a nonsteroidal anti-inflammatory drug are administered to a patient prior to administ... | 06/30/1998 |
| 5716991 | Pharmaceutical compositions comprising paracetamol and L-cysteine or a precursor thereof An improved process for the production of a pharmaceutical composition comprising p-hydroxyacetanilide and L-cysteine or a compound which is converted thereto in vivo comprises mixing p-hydroxyacetanilide and L-cysteine or its precursor in the solid state... | 02/10/1998 |
| 5681564 | Flavored, ready to use activated charcoal antidote To provide a therapeutic dose of an aqueous slurry of activated charcoal to a poisoning victim, an opaque straw is coated internally with a viscous flavoring solution and the slurry is sucked up from an opaque container using the straw. The use of natural... | 10/28/1997 |
| 5674904 | Method for the treatment of cyanide poisoning 2-oxopropanedioic acid is an extremely effective antidote for cyanide poisoning even at low doses.... | 10/07/1997 |
| 5622713 | Method of detoxifying animal suffering from overdose A method for accumulating drugs or other chemicals within synthetic, lipid-like vesicles by means of a pH gradient imposed on the vesicles just prior to use is described. The method is suited for accumulating molecules with basic or acid moieties which ar... | 04/22/1997 |
| 5512598 | Dietary vaccine for inhibiting metabolism of methanol A method for inhibiting the metabolism of methanol in a human is disclosed. The method comprises administering a source of ethanol introduced into the respiratory tract of a human being, permitting the gradual time release of ethanol from the dietary vacc... | 04/30/1996 |
| 5474757 | Prevention of acetaminophen overdose toxicity with organosulfur compounds A method of preventing acetaminophen (APAP)-induced hepatotoxicity utilizing diallyl sulfide (DAS) and diallyl sulfone (DASO2) is disclosed. DAS and DASO2 are prepared as an oral dosage form or injected. In a preferred embodiment, di... | 12/12/1995 |
| 5439894 | Dextrin derivatives for the treatment of acidic conditions Disclosed is a pharmaceutical composition comprising a dextrin derivative in which a proportion of the hydroxyl groups of dextrin are replaced by basic groups. Such compositions are useful for the treatment of acidic conditions.... | 08/08/1995 |
| 5430030 | Nerve gas antidote A prophylactic pretreatment for nerve gas and pesticide poisons which can be administered orally and which comprises the following agents, in combination: a. Pyridostigmine (pyridostigmine bromide) b. Diazepam c. N-methyl-4-pipyridinyl phenylcyclopentanec... | 07/04/1995 |
| 5298504 | Nerve gas antidote A prophylactic pretreatment for nerve gas and pesticide poisons which can be administered orally and which comprises the following agents, in combination: a. Pyridostigmine (pyridostigmine bromide) or physostigmine b. Diazepam or clonazepam c. G 3063, Arpenal,... | 03/29/1994 |
| 5280017 | Use of dextrin derivatives for the treatment of acidic conditions A method of treating acid poisoning in mammals or of lowering blood cholesterol levels in mammals, which involves administering to the mammals a pharmaceutically effective amount of an aminated dextrin where amine groups or residues are present in an amou... | 01/18/1994 |
| 5264207 | Products for cutaneous applications with cosmetic and/or therapeutic effects Products for cutaneous application with cosmetic and/or therapeutic effects, containing one or more active substances. This or these substances are carried by the microspheres of a polymer, dispersed in a liquid in which this polymer is not soluble.... | 11/23/1993 |
| 5258175 | Treatment of poisoning and compositions for use therein A dextrin derivative, in which a proportion of the hydroxyl groups in the dextrin have been replaced by strongly acidic groups, is useful in treatment of poisoning or drug overdose, particularly by compounds having basic groups. Dextrin sulphate is a pref... | 11/02/1993 |
| 5186941 | Vesicle formulation for the controlled release of therapeutic agents Disclosed herein are vesicle compositions for controlled sustained release of an encapsulated therapeutic agent after parenteral administration. By adjusting the osmolarity between the suspending solution and the solution within the vesicles by adjusting ... | 02/16/1993 |
| 5066480 | Method of preventing or reducing adverse reactions to protamine using a thromboxane A2 receptor antagonist A method is provided for preventing reducing or reversing adverse reactions, such as pulmonary hypertension produced when protamine interacts with heparin, by administering a thromboxane A2 receptor antagonist.... | 11/19/1991 |
| 5061477 | Use of cobalt to enhance urinary copper excretion A method for reducing the copper burden in mammals without zincuresis utilizing cobalt salts or chelates.... | 10/29/1991 |
| 5047229 | Treatment of cardiovascular and cerebral toxicity using calcium modulators Calcium modulators can be effectively used to treat cardiovascular and cerebral toxicity induced by materials that alter the normal interaction of neurotransmitters with the calcium transport mechanisms of myocardial and cerebral cells. For example, calci... | 09/10/1991 |
| 5035878 | Use of dithiocarbamates to counteract myelosuppression Various types of biological treatments, including antineoplastic treatments with antineoplastic drugs, can result in damage to the blood-forming function of the bone marrow. This damage can be reversed, at least to some degree, with an effective amount (p... | 07/30/1991 |
| 5028612 | Method for treating emotional numbness An opiate antagonist or a pharmaceutically acceptable salt thereof is used to treat emotional numbness associated with Post Traumatic Stress Disorder and other psychopathologic conditions.... | 07/02/1991 |
| 5023073 | Method of combating flupropadine poisoning using phenothiazines Antidotes to the rat poison flupropadine and substances acting in the same way include compounds which modulate (e.g. inhibit) aminergic systems in the gut or adrenal tissues. Such compounds include tricyclic anti-depressants (e.g. chlorpromazine) and man... | 06/11/1991 |
| 4963345 | Injectable local anesthetic antidote An injectable antidote for local anesthetic is disclosed. In the preferred and illustrated embodiment, it is a liquid injectable having a relatively low pH typically in the range of about 2.0 to as high as about 5.5, the preferred being about 3.5. It inco... | 10/16/1990 |
| 4882146 | Preventing ADP-ribosylation of G-proteins in a living subject Nicotinamide and its analogues (but not nicotinic acid) are effective in preventing or reversing the effects of microbial toxins, e.g. pertussis toxin, which ADP-ribosylate G-proteins.... | 11/21/1989 |
| 4877601 | Adsorbent composition Use of a physiologically inert hydrophobic molecular sieve material to lower the blood alcohol level in the human body in the form of an edible composition or a suppository, the material having a pore size permitting the absorption of ethanol but preventi... | 10/31/1989 |
| 4865837 | Aldoxime-substituted triazolium compounds useful in the treatment of poisoning by phosphorus-containing chemicals A therapeutically effective class of low toxicity aldoxime-substituted trazolium derivatives is disclosed which is effective in the treatment of living species poisoned by organophosphorus chemicals which inactivate the enzyme acetylcholinesterase. In viv... | 09/12/1989 |
| 4771039 | Botulinus toxin neutralizer A botulinus toxin neutralizer comprising heat-treated fat globule membranes of animal milk or gangliosides isolated from fat globule membranes of animal milk. The neutralizer of the former nature is prepared from a material containing fat globules of anim... | 09/13/1988 |
| 4734275 | Anti-curare agents This invention relates to a method for antagonizing induced the neuromuscular blocking effects of certain therapeutic agents and pathological disorders in mammals, which comprises administering to said mammal an antagonizing-effective amount of a compound... | 03/29/1988 |
